Revolution Medicines, Inc.
Clinical-stage precision oncology company developing therapies for RAS-driven cancers.
RVMD | US
Overview
Corporate Details
- ISIN(s):
- US76155X1000
- LEI:
- Country:
- United States of America
- Address:
- 700 SAGINAW DR, 94063 REDWOOD CITY
- Website:
- https://www.revmed.com/
Description
Revolution Medicines, Inc. is a clinical-stage precision oncology company dedicated to discovering and developing novel targeted therapies for cancers driven by the RAS pathway. The company's research focuses on creating innovative small molecule inhibitors that target key nodes within the RAS signaling cascade. Its pipeline is built on a platform designed to address various RAS mutations and associated proteins, aiming to provide transformative treatments for patients with RAS-addicted cancers, which have historically been difficult to treat.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Revolution Medicines, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Revolution Medicines, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Revolution Medicines, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
